Perspective on skeletal health in inflammatory bowel disease

Yazar: van Bodegraven, A. A., Bravenboer, N.
Yayımlandı Osteoporos Int (2019)

Mesalazine is safe for the treatment of IBD

Yazar: D’Haens, G, van Bodegraven, A A
Baskı/Yayın Bilgisi 2004

Signal transducer and activator of transcription 6 gene G2964A polymorphism and inflammatory bowel disease

Yazar: Xia, B, Crusius, J B A, Wu, J, Zwiers, A, Van Bodegraven, A A, Peña, A S
Baskı/Yayın Bilgisi 2003

Tropheryma whipplei, a Potential Commensal Detected in Individuals Undergoing Routine Colonoscopy

Yazar: Grasman, M. E., Pettersson, A. M., Catsburg, A., Koek, A. G., van Bodegraven, A. A., Savelkoul, P. H. M.
Yayımlandı J Clin Microbiol (2015)

Impacts of perianal disease and faecal incontinence on quality of life and employment in 1092 patients with inflammatory bowel disease

Yazar: Vollebregt, P. F., van Bodegraven, A. A., Markus‐de Kwaadsteniet, T. M. L., van der Horst, D., Felt‐Bersma, R. J. F.
Yayımlandı Aliment Pharmacol Ther (2018)

The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn’s disease without a major role for the Saccharomyces cerevisiae mannan-LBP-C...

Yazar: Ouburg, S, Mallant-Hent, R, Crusius, J B A, van Bodegraven, A A, Mulder, C J J, Linskens, R, Peña, A S, Morré, S A
Baskı/Yayın Bilgisi 2005

P637 Incidence rate and clinical outcome of severe COVID-19 in Inflammatory Bowel Disease patients in a population-based setting

Yazar: Rezazadeh Ardabili, A, Creemers, R H, Jonkers, D M A E, Romberg-Camps, M J L, Pierik, M J, van Bodegraven, A A
Yayımlandı J Crohns Colitis (2021)

The nocebo effect challenges the non-medical infliximab switch in practice

Yazar: Boone, N. W., Liu, L., Romberg-Camps, M. J., Duijsens, L., Houwen, C., van der Kuy, P. H. M., Janknegt, R., Peeters, R., Landewé, R. B. M., Winkens, B., van Bodegraven, A. A.
Yayımlandı Eur J Clin Pharmacol (2018)

Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease

Yazar: Lutgens, M W M D, Oldenburg, B, Siersema, P D, van Bodegraven, A A, Dijkstra, G, Hommes, D W, de Jong, D J, Stokkers, P C F, van der Woude, C J, Vleggaar, F P
Baskı/Yayın Bilgisi 2009

Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients

Yazar: de Meij, T. G. J., de Groot, E. F. J., Peeters, C. F. W., de Boer, N. K. H., Kneepkens, C. M. F., Eck, A., Benninga, M. A., Savelkoul, P. H. M., van Bodegraven, A. A., Budding, A. E.
Yayımlandı PLoS One (2018)

Differential association of two PTPN22 coding variants with Crohn’s disease and ulcerative colitis

Yazar: Diaz-Gallo, L M, Espino-Paisán, L, Fransen, K, Gómez-García, M, van Sommeren, S, Cardeña, C, Rodrigo, L, Mendoza, J L, Taxonera, C, Nieto, A, Alcain, G, Cueto, I, López-Nevot, M A, Bottini, N, Barclay, M L, Crusius, J B, van Bodegraven, A A, Wijmenga, C, Ponsioen, C Y, Gearry, R B, Roberts, R L, Weersma, R K, Urcelay, E, Merriman, T R, Alizadeh, B Z, Martin, J
Baskı/Yayın Bilgisi 2010

Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease

Yazar: Severs, M., van Erp, S. J. H., van der Valk, M. E., Mangen, M. J. J., Fidder, H. H., van der Have, M., van Bodegraven, A. A., de Jong, D. J., van der Woude, C. J., Romberg-Camps, M. J. L., Clemens, C. H. M., Jansen, J. M., van de Meeberg, P. C., Mahmmod, N., Ponsioen, C. Y., Bolwerk, C., Vermeijden, J. R., Pierik, M. J., Siersema, P. D., Leenders, M., van der Meulen-de Jong, A. E., Dijkstra, G., Oldenburg, B.
Yayımlandı J Crohns Colitis (2016)